These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1961006)

  • 21. Imatinib sensitizes CLL lymphocytes to chlorambucil.
    Aloyz R; Grzywacz K; Xu ZY; Loignon M; Alaoui-Jamali MA; Panasci L
    Leukemia; 2004 Mar; 18(3):409-14. PubMed ID: 14712290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
    Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M
    Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutathione-S-transferase activity and multidrug resistance phenotype in chronic lymphocytic leukemia: do they have any clinical relevance?
    Di Simone D; Testi R; Caracciolo F; Capochiani E; Ambrogi F; Grassi B; Petrini M
    Haematologica; 1995; 80(2):103-7. PubMed ID: 7543067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutathione depletion in chronic lymphocytic leukemia B lymphocytes.
    Silber R; Farber CM; Papadopoulos E; Nevrla D; Liebes L; Bruck M; Brown R; Canellakis ZN
    Blood; 1992 Oct; 80(8):2038-43. PubMed ID: 1356514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of infrared spectra of CLL cells with their ex vivo sensitivity (MTT assay) to chlorambucil and cladribine.
    Liu KZ; Schultz CP; Johnston JB; Lee K; Mantsch HH
    Leuk Res; 1997; 21(11-12):1125-33. PubMed ID: 9444947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of chlorambucil treatment on cytogenetic parameters in chronic lymphocytic leukemia patients.
    Amiel A; Biton I; Yukla M; Gaber E; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2003 Jun; 143(2):113-9. PubMed ID: 12781444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes.
    Bank BB; Kanganis D; Liebes LF; Silber R
    Cancer Res; 1989 Feb; 49(3):554-9. PubMed ID: 2910477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia.
    Kost SE; Bouchard ED; LaBossière É; Ye X; Queau ML; Liang WS; Banerji V; Gibson SB; Katyal S; Johnston JB
    Leuk Res; 2016 Nov; 50():63-71. PubMed ID: 27683974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
    N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia.
    Bello VE; Aloyz RS; Christodoulopoulos G; Panasci LC
    Biochem Pharmacol; 2002 May; 63(9):1585-8. PubMed ID: 12007561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients.
    Hebb J; Assouline S; Rousseau C; Desjardins P; Caplan S; Egorin MJ; Amrein L; Aloyz R; Panasci L
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):643-51. PubMed ID: 21120481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
    Ganeshaguru K; Wickremasinghe RG; Jones DT; Gordon M; Hart SM; Virchis AE; Prentice HG; Hoffbrand AV; Man A; Champain K; Csermak K; Mehta AB
    Haematologica; 2002 Feb; 87(2):167-76. PubMed ID: 11836167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells.
    Täger M; Kröning H; Thiel U; Ansorge S
    Exp Hematol; 1997 Jul; 25(7):601-7. PubMed ID: 9216735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-beta-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro.
    Begleiter A; Verburg L; Ashique A; Lee K; Israels LG; Mowat MR; Johnston JB
    Leukemia; 1995 Nov; 9(11):1875-81. PubMed ID: 7475278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones.
    Pepper C; Thomas A; Hoy T; Bentley P
    Br J Haematol; 1999 Mar; 104(3):581-8. PubMed ID: 10086798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro chemosensitivity of chronic lymphocytic leukemia B-cells to multidrug regimen (CEOP) compounds using the MTT colorimetric assay.
    Morabito F; Messina G; Oliva B; Ramirez F; Callea V; Brugiatelli M; Nobile F
    Haematologica; 1993; 78(4):213-8. PubMed ID: 8294052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy.
    Callea V; Brugiatelli M; Stelitano C; Gentile M; Nobile F; Morabito F
    Leuk Lymphoma; 2006 Nov; 47(11):2314-20. PubMed ID: 17107903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutathione-s-transferase pi expression in leukaemia: a comparative analysis with mdr-1 data.
    Holmes J; Wareing C; Jacobs A; Hayes JD; Padua RA; Wolf CR
    Br J Cancer; 1990 Aug; 62(2):209-12. PubMed ID: 2386736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vivo study of spontaneous and therapy-induced apoptosis in patients with chronic lymphocytic leukemia treated with chlorambucil].
    Marjanović S; Brajusković G; Skaro-Milić A; Malesević M
    Vojnosanit Pregl; 1999; 56(4):377-82. PubMed ID: 10528523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.